Usually, the FDA is framed as a correction to misalignments between the interests of consumers and pharmaceutical companies. People want effective medicine but pharmaceutical companies can give them sugar and sawdust for cheap and it is difficult for patients to find out.
The Ranbaxxy case suggests that the FDA isn’t that good at preventing that from happening. They mostly work on a basis where they trust pharmaceutical companies to do what they are saying they do.
The Ranbaxxy case suggests that the FDA isn’t that good at preventing that from happening. They mostly work on a basis where they trust pharmaceutical companies to do what they are saying they do.